Abstract
Purpose
The aim of this study was to perform a thermodynamic and kinetic investigation on the crucial factors affecting the cocrystallization between adefovir dipivoxil (AD) and saccharin (SAC).
Methods
Phase solubility diagrams and ternary phase diagrams were constructed based on the solubility data of AD, SAC and their cocrystals in ethanol, isopropanol and ethyl acetate at different temperatures. The conductimetric method was used to determine the induction time. A quantitative and intuitive technique modified from dissolution testing was employed to investigate the cocrystallization kinetics.
Results
AD-SAC cocrystals exhibited different crystal habits but only one cocrystal polymorph was confirmed. The effects of several crucial factors, including the input amounts of two components, AD/SAC ratio, solvent and temperature, on the crystallization of single-component alone, cocrystal formation, cocrystal stability, supersaturation, nucleation, crystal growth and cocrystal yield were determined. Thermodynamic and kinetic parameters provided the rationale for this spontaneous cocrystallization system without the need of solvent evaporation and temperature change.
Conclusions
This systemic investigation enriched the present understanding of thermodynamics and kinetics of cocrystals and built the groundwork for AD-SAC cocrystal scale-up.
Similar content being viewed by others
Abbreviations
- AD:
-
Adefovir dipivoxil
- API:
-
Active pharmaceutical ingredient
- CBZ:
-
Carbamazepine
- CCF:
-
Cocrystal former
- IND:
-
Indomethacin
- K 11 :
-
Complexation constant
- K sp :
-
Solubility product
- NCT:
-
Nicotinamide
- PSD:
-
Phase solubility diagram
- PTFE:
-
Polytetrafluoroethylene
- SAC:
-
Saccharin
- SEM:
-
Scanning electron microscopy
- TPD:
-
Ternary phase diagram
- XRPD:
-
X-ray powder diffraction
References
Miroshnyk I, Mirza S, Sandler N. Pharmaceutical co-crystals-an opportunity for drug product enhancement. Expert Opin Drug Del. 2009;6(4):333–41.
Shayanfar A, Asadpour-Zeynali K, Jouyban A. Solubility and dissolution rate of a carbamazepine–cinnamic acid cocrystal. J Mol Liq. 2013;187:171–6.
Gao Y, Zu H, Zhang J. Enhanced dissolution and stability of adefovir dipivoxil by cocrystal formation. J Pharm Pharmacol. 2011;63(4):483–90.
Trask AV, Motherwell WD, Jones W. Physical stability enhancement of theophylline via cocrystallization. Int J Pharm. 2006;320(1):114–23.
Karki S, Friščić T, Fábián L, Laity PR, Day GM, Jones W. Improving mechanical properties of crystalline solids by cocrystal formation: new compressible forms of paracetamol. Adv Mater. 2009;21(38–9):3905–9.
Jung MS, Kim JS, Kim MS, Alhalaweh A, Cho W, Hwang SJ, et al. Bioavailability of indomethacin-saccharin cocrystals. J Pharm Pharmacol. 2010;62(11):1560–8.
Chow SF, Chen M, Shi L, Chow AH, Sun CC. Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide. Pharm Res. 2012;29(7):1854–65.
Ainouz A, Authelin JR, Billot P, Lieberman H. Modeling and prediction of cocrystal phase diagrams. Int J Pharm. 2009;374(1):82–9.
Schultheiss N, Newman A. Pharmaceutical cocrystals and their physicochemical properties. Cryst Growth Des. 2009;9(6):2950–67.
Padrela L, Rodrigues MA, Velaga SP, Fernandes AC, Matos HA, De Azevedo EG. Screening for pharmaceutical cocrystals using the supercritical fluid enhanced atomization process. J Supercrit Fluid. 2010;53(1):156–64.
Nehm SJ, Rodríguez-Spong B, Rodriguez-Hornedo N. Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation. Cryst Growth Des. 2006;6(2):592–600.
Chiarella RA, Davey RJ, Peterson ML. Making co-crystals the utility of the ternary phase diagram. Cryst Growth Des. 2007;7(7):1223–6.
Gagniere E, Mangin D, Puel F, Bebon C, Klein JP, Monnier O, et al. Cocrystal formation in solution: in situ solute concentration monitoring of the two components and kinetic pathways. Cryst Growth Des. 2009;9(8):3376–83.
Derdour L, Fevotte G, Puel F, Carvin P. Real-time evaluation of the concentration of impurities during organic solution crystallization. Powder Technol. 2003;129(1):1–7.
Gagniere E, Mangin D, Puel F, Rivoire A, Monnier O, Garcia E, et al. Formation of co-crystals: kinetic and thermodynamic aspects. J Cryst Growth. 2009;311(9):2689–95.
Starrett JEJ, Tortolani DR, Russell J, Hitchcock MJ, Whiterock V, Martin JC, et al. Synthesis, oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(phosphonomethoxy) ethyl] adenine (PMEA). J Med Chem. 1994;37(12):1857–64.
Gao Y, Gao J, Liu Z, Kan H, Zu H, Sun W, et al. Coformer selection based on degradation pathway of drugs: a case study of adefovir dipivoxil-saccharin and adefovir dipivoxil-nicotinamide cocrystals. Int J Pharm. 2012;438(1–2):327–35.
Hickey MB, Peterson ML, Scoppettuolo LA, Morrisette SL, Vetter A, Guzmán H, et al. Performance comparison of a co-crystal of carbamazepine with marketed product. Eur J Pharm Biopharm. 2007;67(1):112–9.
Nokhodchi A, Bolourtchian N, Dinarvand R. Crystal modification of phenytoin using different solvents and crystallization conditions. Int J Pharm. 2003;250(1):85–97.
Zhang J, Zu H, Gao Y. Formation thermodynamics of adefovir dipivoxil-saccharin co-crystals. Acta Phys-Chim Sin. 2011;27(3):547–52.
Good DJ, Rodríguez-Hornedo N. Solubility advantage of pharmaceutical cocrystals. Cryst Growth Des. 2009;9(5):2252–64.
Schartman RR. On the thermodynamics of cocrystal formation. Int J Pharm. 2009;365(1):77–80.
Crosio MP, Jullien M. Fluorescence study of precrystallization of ribonuclease A: effect of salts. J Cryst Growth. 1992;122(1):66–70.
Michinomae M, Mochizuki M, Ataka M. Electron microscopic studies on the initial process of lysozyme crystal growth. J Cryst Growth. 1999;197(1):257–62.
Kozlovskii MI, Wakita H, Masuda I. Analyses of precipitation processes of bis (dimethylglyoximato) Ni (II) and related complexes. J Cryst Growth. 1983;61(2):377–82.
Kuldipkumar A, Kwon GS, Zhang GG. Determining the growth mechanism of tolazamide by induction time measurement. Cryst Growth Des. 2007;7(2):234–42.
Van der Leeden MC, Kashchiev D, Van Rosmalen GM. Precipitation of barium sulfate: Induction time and the effect of an additive on nucleation and growth. J Colloid Interf Sci. 1992;152(2):338–50.
Söhnel O, Mullin JW. A method for the determination of precipitation induction periods. J Cryst Growth. 1978;44(4):377–82.
Childs SL, Rodríguez-Hornedo N, Reddy LS, Jayasankar A, Maheshwari C, McCausland L, et al. Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine. CrystEngComm. 2008;10(7):856–64.
Alhalaweh A, Sokolowski A, Rodríguez-Hornedo N, Velaga SP. Solubility behavior and solution chemistry of indomethacin cocrystals in organic solvents. Cryst Growth Des. 2011;11(9):3923–9.
Higuchi T, Connors KA. Phase-solubility techniques. Adv Anal Chem Instrum. 1965;4(2):117–212.
Alhalaweh A, Velaga SP. Formation of cocrystals from stoichiometric solutions of incongruently saturating systems by spray drying. Cryst Growth Des. 2010;10(8):3302–5.
Rahman Z, Agarabi C, Zidan AS, Khan SR, Khan MA. Physico-mechanical and stability evaluation of carbamazepine cocrystal with nicotinamide. AAPS PharmSciTech. 2011;12(2):693–704.
Lee KC, Kim KJ. Effect of supersaturation and thermodynamics on co-crystal formation. Chem Eng Technol. 2011;34(4):619–23.
Rodríguez-Hornedo N, Nehm SJ, Seefeldt KF, Pagán-Torres Y, Falkiewicz CJ. Reaction crystallization of pharmaceutical molecular complexes. Mol Pharmaceut. 2006;3(3):362–7.
Yi WT, Yan CY, Ma PH. Crystallization kinetics of Li2CO3 from LiHCO3 solutions. J Cryst Growth. 2010;312(16):2345–50.
Tung HH, Paul EL, Midler M, McCauley JA. Crystallization of organic compounds: an industrial perspective. New Jersey: Wiley-AIChE; 2009.
Selvaraju K, Valluvan R, Kumararaman S. Experimental determination of metastable zone width, induction period, interfacial energy and growth of nonlinear optical Hippuric acid single crystal. Mater Lett. 2006;60(12):1549–53.
Liu X, Wang Z, Duan A, Zhang G, Wang X, Sun Z, et al. Measurement of l-arginine trifluoroacetate crystal nucleation kinetics. J Cryst Growth. 2008;310(10):2590–2.
Nielsen AE, Sarig S. Homogeneous nucleation of droplets and interfacial tension in the liquid system methanol-water-tribromomethane. J Cryst Growth. 1971;8(1):1–7.
Storey RA, Ymén I. Solid state characterization of pharmaceuticals. Chichester: Wiley-Blackwell; 2011.
Desikan S, Anderson SR, Meenan PA, Toma PH. Crystallization challenges in drug development: scale-up from laboratory to pilot plant and beyond. Curr Opin Drug Discov Dev. 2000;3(6):723–33.
Beckmann W. Crystallization- basic concepts and industrial applications. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2013.
Acknowledgments
This research was supported by the Important National Science & Technology Specific Projects (NO. 2011ZX09201-101-02), The National Natural Science Fund (NO. 81202988) and the Fundamental Research Funds for the Central Universities (Program No. JKP2011006).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ma, K., Zhang, Y., Kan, H. et al. Thermodynamic and Kinetic Investigation on the Crucial Factors Affecting Adefovir Dipivoxil-Saccharin Cocrystallization. Pharm Res 31, 1766–1778 (2014). https://doi.org/10.1007/s11095-013-1281-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-013-1281-3